Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-21

FDA Approved: ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE) — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approves Adrenalin, a formulation of epinephrine in sodium chloride, under the original application submitted by Par Health USA, LLC. This marks the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADRENALIN (Epinephrine)

Snippet

ORIG AP for ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE) (EPINEPHRINE IN SODIUM CHLORIDE)